Evolent Health (EVH) Misses Q4 EPS by 3c, Offers Guidance

Evolent Health (NYSE: EVH) reported Q4 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $193.3 million versus the consensus estimate of $188.74 million.

GUIDANCE:

Evolent Health sees Q1 2019 revenue of $188-197 million, versus the consensus of $205.02 million.

Evolent Health sees FY2019 revenue of $805-880 million, versus the consensus of $849.83 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook
• Simply Good Foods posts Q3 loss, cuts fiscal 2026 outlook
• Piper Sandler Reiterates Overweight Rating on Reddit (RDDT)